Comparable stake leader
BlackRock, Inc.
SEC ownership of AMICUS THERAPEUTICS, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001178879.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Parsed ownership sources
-
13F and 13D/G
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BlackRock, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001178879
- Issuer location
- Princeton, NJ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of AMICUS THERAPEUTICS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
13F
13D/G
Lead comparable stake: 7.4%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 7.4%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
7.4%
UBS Group AG
5.5%
GOLDMAN SACHS GROUP INC
5.3%
VANGUARD CAPITAL MANAGEMENT LLC
5.2%
Avoro Capital Advisors LLC
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
7.4%
from 13D/G
|
$489,891,036
33,879,048 shares
|
— | 31 Mar 2026 |
| UBS Group AG |
13D/G
13F
Company
|
5.5%
|
$247,870,674
17,141,817 shares
|
$0 | 31 Mar 2026 |
| GOLDMAN SACHS GROUP INC |
13D/G
13F
THE GOLDMAN SACHS GROUP, INC. · Company
|
5.3%
|
$242,670,074
16,782,163 shares
|
$0 | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5.2%
|
$236,433,103
16,350,837 shares
|
$0 | 31 Mar 2026 |
| Avoro Capital Advisors LLC |
13D/G
|
4.9%
|
$118,397,000
15,025,000 shares
|
-$43,143,000 | 30 Sep 2025 |
| Redmile Group, LLC |
13D/G
|
4.6%
|
$106,667,402
14,184,495 shares
|
$0 | 31 Dec 2024 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13D/G
|
3.4%
|
$151,763,799
10,627,717 shares
|
-$76,348,548 | 31 Dec 2025 |
| PERCEPTIVE ADVISORS LLC |
13D/G
|
2.4%
|
$43,290,927
7,412,830 shares
|
-$82,061,910 | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$5,414,949.
Buys
$0
Insiders: 0
Sells
$5,414,949
Insiders: 4
Net
-$5,414,949
Shares: -478,950
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 478,950
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 22,500 | $0 | $322,839 | -$322,839 |
| 6-9 | 0 | 456,450 | $0 | $5,092,110 | -$5,092,110 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to AMICUS THERAPEUTICS, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
John F. Crowley
Net 12M change
-$5,414,949
Latest report
27 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| John F. Crowley | Executive Chairman, Director | $8,521,769 | Mixed | 01 Mar 2024 | ||
| Daphne Quimi | Chief Financial Officer | $4,926,692 | Mixed | 17 Jan 2023 | ||
| Robert Essner | Director | $384,647 | Mixed | 10 Jun 2021 | ||
| Simon N.r. Harford | Chief Financial Officer | $0 | Mixed | 27 Apr 2026 | ||
| Michael Raab | Director | $0 | Mixed | 27 Apr 2026 | ||
| Lynn Dorsey Bleil | Director | $0 | Mixed | 27 Apr 2026 | ||
| Jeff Castelli | Chief Development Officer | $0 | -$773,659 | -100% | Mixed | 27 Apr 2026 |
| Eiry Roberts | Director | $0 | Mixed | 27 Apr 2026 | ||
| Michael Aaron Kelly | Director | $0 | Mixed | 27 Apr 2026 | ||
| Burke W. Whitman | Director | $0 | Mixed | 27 Apr 2026 | ||
| Margaret G. Mcglynn | Director | $0 | Mixed | 27 Apr 2026 | ||
| Bradley L. Campbell | President and CEO, Director | $0 | -$2,534,566 | -100% | Mixed | 27 Apr 2026 |
| David Michael Clark | Chief People Officer | $0 | -$1,148,246 | -100% | Mixed | 27 Apr 2026 |
| Samantha Prout | Chief Accounting Officer | $0 | Mixed | 27 Apr 2026 | ||
| Ellen Rosenberg | Chief Legal Officer | $0 | -$958,478 | -100% | Mixed | 27 Apr 2026 |
| Craig A. Wheeler | Director | $0 | Mixed | 27 Apr 2026 | ||
| Glenn Sblendorio | Director | $0 | Mixed | 27 Apr 2026 |
Recent insider transactions for AMICUS THERAPEUTICS, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Craig A. Wheeler | FOLD | Common Stock | Disposed to Issuer | -100% | -84,631 | 0 | 27 Apr 2026 | Direct | ||
| Craig A. Wheeler | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -313,630 | 0 | 27 Apr 2026 | Direct | ||
| Margaret G. Mcglynn | FOLD | Common Stock | Disposed to Issuer | -100% | -94,631 | 0 | 27 Apr 2026 | Direct | ||
| Margaret G. Mcglynn | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -303,630 | 0 | 27 Apr 2026 | Direct | ||
| Burke W. Whitman | FOLD | Common Stock | Disposed to Issuer | -100% | -118,598 | 0 | 27 Apr 2026 | Direct | ||
| Burke W. Whitman | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -273,885 | 0 | 27 Apr 2026 | Direct | ||
| Glenn Sblendorio | FOLD | Common Stock | Disposed to Issuer | -100% | -142,564 | 0 | 27 Apr 2026 | Direct | ||
| Glenn Sblendorio | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -303,630 | 0 | 27 Apr 2026 | Direct | ||
| Eiry Roberts | FOLD | Common Stock | Disposed to Issuer | -100% | -76,275 | 0 | 27 Apr 2026 | Direct | ||
| Eiry Roberts | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -233,861 | 0 | 27 Apr 2026 | Direct | ||
| Lynn Dorsey Bleil | FOLD | Common Stock | Disposed to Issuer | -100% | -113,941 | 0 | 27 Apr 2026 | Direct | ||
| Lynn Dorsey Bleil | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -281,999 | 0 | 27 Apr 2026 | Direct | ||
| Michael Aaron Kelly | FOLD | Common Stock | Disposed to Issuer | -100% | -72,468 | 0 | 27 Apr 2026 | Direct | ||
| Michael Aaron Kelly | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -229,347 | 0 | 27 Apr 2026 | Direct | ||
| Michael Raab | FOLD | Common Stock | Disposed to Issuer | -100% | -115,857 | 0 | 27 Apr 2026 | Direct | ||
| Michael Raab | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -303,630 | 0 | 27 Apr 2026 | Direct | ||
| Samantha Prout | FOLD | Common Stock | Disposed to Issuer | -100% | -125,951 | 0 | 27 Apr 2026 | Direct | ||
| Samantha Prout | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -205,022 | 0 | 27 Apr 2026 | Direct | ||
| Jeff Castelli | FOLD | Common Stock | Disposed to Issuer | -100% | -427,089 | 0 | 27 Apr 2026 | Direct | ||
| Jeff Castelli | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -673,537 | 0 | 27 Apr 2026 | Direct | ||
| David Michael Clark | FOLD | Common Stock | Disposed to Issuer | -100% | -221,811 | 0 | 27 Apr 2026 | Direct | ||
| David Michael Clark | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -675,720 | 0 | 27 Apr 2026 | Direct | ||
| Ellen Rosenberg | FOLD | Common Stock | Disposed to Issuer | -100% | -15,000 | 0 | 27 Apr 2026 | By Spouse | ||
| Ellen Rosenberg | FOLD | Common Stock | Disposed to Issuer | -100% | -463,898 | 0 | 27 Apr 2026 | Direct | ||
| Ellen Rosenberg | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -786,095 | 0 | 27 Apr 2026 | Direct | ||
| Simon N.r. Harford | FOLD | Common Stock | Disposed to Issuer | -100% | -143,595 | 0 | 27 Apr 2026 | Direct | ||
| Simon N.r. Harford | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -438,633 | 0 | 27 Apr 2026 | Direct | ||
| Bradley L. Campbell | FOLD | Common Stock | Disposed to Issuer | -100% | -1,008,680 | 0 | 27 Apr 2026 | Direct | ||
| Bradley L. Campbell | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -1,964,409 | 0 | 27 Apr 2026 | Direct | ||
| Bradley L. Campbell | FOLD | Common Stock | Sale | -2.2% | $322,839 | $14.35 | -22,500 | 998,680 | 02 Mar 2026 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Sale | -6.84% | $1,073,182 | $14.31 | -75,000 | 1,021,180 | 20 Jan 2026 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Options Exercise | 7.34% | 75,000 | 1,096,180 | 20 Jan 2026 | Direct | ||
| Bradley L. Campbell | FOLD | Stock Options (right to buy) | Options Exercise | -100% | -75,000 | 0 | 20 Jan 2026 | Direct | ||
| Ellen Rosenberg | FOLD | Common Stock | Tax liability | -6.01% | -29,683 | 464,601 | 03 Jan 2026 | Direct | ||
| Jeff Castelli | FOLD | Common Stock | Tax liability | -5.34% | -23,102 | 409,311 | 03 Jan 2026 | Direct | ||
| Samantha Prout | FOLD | Common Stock | Tax liability | -8.86% | -12,240 | 125,951 | 03 Jan 2026 | Direct | ||
| David Michael Clark | FOLD | Common Stock | Tax liability | -7.7% | -18,498 | 221,811 | 03 Jan 2026 | Direct | ||
| Ellen Rosenberg | FOLD | Common Stock | Tax liability | -2.64% | -13,426 | 494,284 | 02 Jan 2026 | Direct | ||
| Jeff Castelli | FOLD | Common Stock | Tax liability | -1.57% | -6,905 | 432,413 | 02 Jan 2026 | Direct | ||
| Samantha Prout | FOLD | Common Stock | Tax liability | -2.43% | -3,443 | 138,191 | 02 Jan 2026 | Direct | ||
| David Michael Clark | FOLD | Common Stock | Tax liability | -2.19% | -5,381 | 240,309 | 02 Jan 2026 | Direct | ||
| Bradley L. Campbell | FOLD | Common Stock | Tax liability | -9.61% | -108,602 | 1,021,180 | 26 Dec 2025 | Direct | ||
| Simon N.r. Harford | FOLD | Common Stock | Tax liability | -33.2% | -71,303 | 143,595 | 26 Dec 2025 | Direct | ||
| David Michael Clark | FOLD | Common Stock | Sale | -9.45% | $363,380 | $14.17 | -25,642 | 245,690 | 19 Dec 2025 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Sale | -6.45% | $846,011 | $10.86 | -77,926 | 1,129,782 | 15 Dec 2025 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Options Exercise | 6.19% | 70,426 | 1,207,708 | 15 Dec 2025 | Direct | ||
| Bradley L. Campbell | FOLD | Stock Options (right to buy) | Options Exercise | -100% | -70,426 | 0 | 15 Dec 2025 | Direct | ||
| David Michael Clark | FOLD | Common Stock | Sale | -8.63% | $282,073 | $11.00 | -25,643 | 271,332 | 15 Dec 2025 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Sale | -1.27% | $146,011 | $10.01 | -14,587 | 1,137,282 | 01 Dec 2025 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Options Exercise | 1.28% | 14,587 | 1,151,869 | 01 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.